# Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-da-22-019-leveraging-artificial-intelligence-ai-tools-for-substance/  
Official notice: https://www.grants.gov/search-results-detail/332714

> National Institutes of Health offered grants to small businesses. Applications closed on August 10, 2021.

| Field | Value |
|---|---|
| Opportunity number | RFA-DA-22-019 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | August 10, 2021 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.279 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) solicits grant applications from small business concerns (SBCs) to develop Artificial Intelligence (AI)-related technologies for drug discovery and drug development for Substance Use Disorders (SUD), excluding alcohol use disorder

## Questions people ask

### Is RFA-DA-22-019 still open?

No. It closed on August 10, 2021.

### Who can apply for Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed)?

Closed August 10, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-DA-22-019?

NIH RePORTER lists 3 projects funded under RFA-DA-22-019 in fiscal 2022, at 3 institutions. The most were at Nemalife Inc., Verisim Life, Inc., Genecentrix, Inc.

### Who has won Drug Use and Addiction Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.